Articles for tag: Afford, African, Bavarian, Costly, Faces, Mpox, Nations, Nordic, outbreaks, Pressure, Prices, Rising, Shots, Struggle, Vaccine

Market News

Bavarian Nordic faces pressure to lower mpox vaccine prices as African nations struggle to afford costly shots amidst rising outbreaks.

Bavarian Nordic faces pressure to lower mpox vaccine prices as African nations struggle to afford costly shots amidst rising outbreaks.

Bavarian Nordic A/S’s mpox vaccine pricing is becoming a major hurdle in securing millions of doses for African nations facing health crises. With the price set at around $100 to $141 per dose, it far exceeds what many African countries can afford, especially given ongoing health challenges like cholera and malaria. As UNICEF and other ...

Current Affairs Q&A: AstraZeneca Covid Vaccine Linked To New Fatal Blood Clotting Disorder, Study Finds

Today’s Current Affairs: AstraZeneca Covid Vaccine Linked To Rare Blood Clotting Disorder If you’re keeping up with the latest news, you might have heard about the recent findings regarding the AstraZeneca Covid-19 vaccine. Researchers have discovered a rare but fatal blood clotting disorder known as vaccine-induced immune thrombocytopenia and thrombosis (VITT) linked to the vaccine. ...

Market News

Big News: Novavax and Sanofi Partner Up to Co-commercialize COVID-19 Vaccine & Create New Combo Vaccines

Biopharmaceutical companies Novavax and Sanofi have recently announced a co-exclusive licensing agreement to co-commercialize their COVID-19 vaccine and collaborate on developing new combination vaccines for COVID-19 and influenza. This partnership has the potential to greatly impact the fight against the ongoing pandemic and future outbreaks. Click to Claim Latest Airdrop for FREE Claim in 15 ...

DeFi Explained: Simple Guide Green Crypto and Sustainability China’s Stock Market Rally and Outlook The Future of NFTs The Rise of AI in Crypto